481 related articles for article (PubMed ID: 36671446)
1. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.
Gaál Z
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671446
[TBL] [Abstract][Full Text] [Related]
2. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
[TBL] [Abstract][Full Text] [Related]
3. Advances in epigenetic therapeutics with focus on solid tumors.
Jin N; George TL; Otterson GA; Verschraegen C; Wen H; Carbone D; Herman J; Bertino EM; He K
Clin Epigenetics; 2021 Apr; 13(1):83. PubMed ID: 33879235
[TBL] [Abstract][Full Text] [Related]
4. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy.
Hussain S; Tulsyan S; Dar SA; Sisodiya S; Abiha U; Kumar R; Mishra BN; Haque S
Semin Cancer Biol; 2022 Aug; 83():441-451. PubMed ID: 34182144
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics and oncology.
Mummaneni P; Shord SS
Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
Maury E; Hashizume R
Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
[TBL] [Abstract][Full Text] [Related]
7. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
8. The growing role of epigenetics in childhood cancers.
Panditharatna E; Filbin MG
Curr Opin Pediatr; 2020 Feb; 32(1):67-75. PubMed ID: 31895160
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
10. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G
Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153
[TBL] [Abstract][Full Text] [Related]
11. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
Zhang J; Huang L; Ge G; Hu K
Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
Ramakrishnan S; Pili R
Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
[TBL] [Abstract][Full Text] [Related]
14. Targeting of epigenetic regulators in neuroblastoma.
Jubierre L; Jiménez C; Rovira E; Soriano A; Sábado C; Gros L; Llort A; Hladun R; Roma J; Toledo JS; Gallego S; Segura MF
Exp Mol Med; 2018 Apr; 50(4):1-12. PubMed ID: 29700278
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.
Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN
Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in cancer: Fundamentals and Beyond.
Biswas S; Rao CM
Pharmacol Ther; 2017 May; 173():118-134. PubMed ID: 28188812
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents.
Santini V; Melnick A; Maciejewski JP; Duprez E; Nervi C; Cocco L; Ford KG; Mufti G
Crit Rev Oncol Hematol; 2013 Nov; 88(2):231-45. PubMed ID: 23838480
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine.
Hui L; Ziyue Z; Chao L; Bin Y; Aoyu L; Haijing W
Eur J Immunol; 2023 Apr; 53(4):e2048980. PubMed ID: 36647268
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics in lung cancer diagnosis and therapy.
Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
